Song Huang

Dr. Song Huang

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Carbohydrate Polymers
Verified
Journal Article
Closed access
LHLian He
Lian He
XYXiaoteng Yan
Xiaoteng Yan
JLJian Liang
Jian Liang
SLShijie Li
Shijie Li
HHHongrui He
Hongrui He
SHSong Huang
Song Huang

1 October 2019 in Pharmacological Research
Verified
Journal Article
Closed access
JLJian Liang
Jian Liang
HLHailun Li
Hailun Li
JCJianqiang Chen
Jianqiang Chen
LHLian He
Lian He
XDXianhua Du
Xianhua Du
SHShaozhen Hou
Shaozhen Hou

1 April 2018 in Carbohydrate Polymers
Verified
Journal Article
Closed access
JLJian Liang
Jian Liang
SCShuxian Chen
Shuxian Chen
JCJianhui Chen
Jianhui Chen
JLJizong Lin
Jizong Lin
QXQingping Xiong
Qingping Xiong
XLXiaoping Lai
Xiaoping Lai

1 February 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
JLJian Liang
Jian Liang
SCShuxian Chen
Shuxian Chen
YHYoudong Hu
Youdong Hu
YYYiqi Yang
Yiqi Yang
JYJun Yuan
Jun Yuan
SHSong Huang
Song Huang

1 October 2020 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
DLDan Li
Dan Li
LGLiang Gao
Liang Gao
MLMuxia Li
Muxia Li
YLYingyi Luo
Yingyi Luo
YXYizhen Xie
Yizhen Xie
SHSong Huang
Song Huang
Side effects of chemotherapy are burning questions for physicians and patients involved in cancers. Ganoderma lucidum is a widely consumed traditional Chinese medicine and edible mushroom with multiple functional properties. The present study aims to investigate the potential of polysaccharides from spore of G. lucidum (SGP) on small intestinal barrier function recovery against paclitaxel (PTX) challenge in a breast cancer mice model and IEC-6 cell line. The 4T1 tumor-bearing mice were treated with PTX together with four-week daily oral administration of SGP. Results indicated that combination of PTX and SGP reversed body weight lost and remolded the histology of small intestine, accompanied with promoted proliferation but suppressed apoptosis in intestinal cells. Intestinal barrier function was enhanced by the combination as indicated by reduced endotoxemia and the up-regulation of tight junction proteins, including Zonula occludens-1 (ZO-1), E-cadherin, β-catenin and Occludin. The protection of SGP was further confirmed in IEC-6 cells affected by PTX in vitro. The combination treatment prevented PTX-induced apoptosis in IEC-6 by inhibiting microtubule polymerization, and the aforementioned tight junction proteins were also upregulated. These findings suggest a promising protective effect of SGP against small intestinal barrier injury caused by PTX, highlighting its clinical implication against the chemotherapy side effects.

10 June 2020 in PeerJ
Verified
Journal Article
Open access
PDF file
ZYZerui Yang
Zerui Yang
WAWenli An
Wenli An
SLShanshan Liu
Shanshan Liu
YHYuying Huang
Yuying Huang
CXChunzhu Xie
Chunzhu Xie
XZXia-Sheng Zheng
Xia-Sheng Zheng
Background: Dextrorotatory borneol (D-borneol), a cyclic monoterpene, is widely used in traditional Chinese medicine as an efficient topical analgesic drug. Fresh leaves of Cinnamomum trees, e.g., C. burmannii and C. camphor, are the main sources from which D-borneol is extracted by steam distillation, yet with low yields. Insufficient supply of D-borneol has hampered its clinical use and production of patent remedies for a long time. Biological synthesis of D-borneol offers an additional approach; however, mechanisms of D-borneol biosynthesis remain mostly unresolved. Hence, it is important and necessary to elucidate the biosynthetic pathway of D-borneol. Results: Comparative analysis on the gene expression patterns of different D-borneol production C. burmannii samples facilitates elucidation on the underlying biosynthetic pathway of D-borneol. Herein, we collected three different chemotypes of C. burmannii, which harbor different contents of D-borneol.A total of 100,218 unigenes with an N50 of 1,128 bp were assembled de novo using Trinity from a total of 21.21 Gb clean bases. We used BLASTx analysis against several public databases to annotate 45,485 unigenes (45.38%) to at least one database, among which 82 unigenes were assigned to terpenoid biosynthesis pathways by KEGG annotation. In addition, we defined 8,860 unigenes as differentially expressed genes (DEGs), among which 13 DEGs were associated with terpenoid biosynthesis pathways. One 1-deoxy-D-xylulose-5-phosphate synthase (DXS) and two monoterpene synthase, designated as CbDXS9, CbTPS2 and CbTPS3, were up-regulated in the high-borneol group compared to the low-borneol and borneol-free groups, and might be vital to biosynthesis of D-borneol in C. burmannii. In addition, we identified one WRKY, two BHLH, one AP2/ERF and three MYB candidate genes, which exhibited the same expression patterns as CbTPS2 and CbTPS3, suggesting that these transcription factors might potentially regulate D-borneol biosynthesis. Finally, quantitative real-time PCR was conducted to detect the actual expression level of those candidate genes related to the D-borneol biosynthesis pathway, and the result showed that the expression patterns of the candidate genes related to D-borneol biosynthesis were basically consistent with those revealed by transcriptome analysis. Conclusions: We used transcriptome sequencing to analyze three different chemotypes of C. burmannii, identifying three candidate structural genes (one DXS, two monoterpene synthases) and seven potential transcription factor candidates (one WRKY, two BHLH, one AP2/ERF and three MYB) involved in D-borneol biosynthesis. These results provide new insight into our understanding of the production and accumulation of D-borneol in C. burmannii.